MicrobiomeTrials
  • Search Trials
  • Conditions
  • Learn
  • About
Data source: ClinicalTrials.gov
This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Sign up for updates
Loading filters…
Showing 1486 trials for Obesity & Metabolic Health
Lactobacillus Acidophilus and Inulin for Cognitive Impairment in ObesityRecruiting
Obesity (Disorder)
This randomized crossover clinical trial aims to evaluate the effect of a synbiotic containing Lactobacillus acidophilus…
Huixquilucan, MexicoEst. completion Feb 2, 2027
View Trial →
The Role of the Amylin Analogue Cagrilintide in Bone MetabolismPhase 1Recruiting
Obesity
In this study we will investigate how the medicine cagrilintide affects bone health in women after menopause with obesit…
Herlev, DenmarkEst. completion May 3, 2028
View Trial →
A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2DPhase 1Recruiting
ObesityType 2 Diabetes
The trial will enroll healthy volunteers and individuals living with obesity, with and without Type 2 Diabetes. The stud…
Neuss, GermanyEst. completion Dec 2028
View Trial →
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia PatientsPhase 2Recruiting
Endometrial NeoplasmsAtypical Endometrial HyperplasiaProgesterone Resistance
To investigate the efficacy of GnRHa plus letrozole vs Diane-35 plus metformin in non-obese progestin-insensitive early-…
Shanghai, ChinaEst. completion Mar 30, 2028
View Trial →
Endo-Band: Endoscopic Band Ligation for Weight LossRecruiting
Obesity
To the best of our knowledge, this is the first study to use endoscopic band ligation for weight loss. All ligatures wil…
Giza, EgyptEst. completion Jan 1, 2029
View Trial →
Susceptibility to Infectious Diseases in ObesityRecruiting
ObesityType2diabetesGut MicrobiotaChronic Disease
The role of intestinal microbiota is becoming ever more important in the context of obesity, type II diabetes (T2D), and…
Novara, ItalyEst. completion Jan 31, 2027
View Trial →
Spinal Cord Injury Model Systems (SCIMS) - Education ModuleRecruiting
Spinal Cord InjuriesObesityCardiometabolic Syndrome
The purpose of this study is to find out if receiving education regarding increased risks of cardiometabolic disease hel…
Washington D.C., United StatesEst. completion Oct 31, 2026
View Trial →
Safety and Effectiveness of Orbera365™ Intragastric Balloon SystemRecruiting
Obesity
This is a prospective, multi-center, standard of care registry offered to subjects in the EU only that have already agre…
Prague, CzechiaEst. completion Apr 7, 2028
View Trial →
A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 DiabetesPhase 3Recruiting
ObesityOverweightType 2 Diabetes Mellitus (T2DM)
The purpose of this study is to assess the efficacy and safety of enicepatide, a dual glucagon-like peptide-1 (GLP-1)/gl…
Zhengzhou, ChinaEst. completion Feb 24, 2028
View Trial →
The Evira Study: Additional Support During Obesity TreatmentRecruiting
Childhood ObesityTreatment Adherence
The goal of this clinical trial is to evaluate the effect of adding a digi-physical treatment tool as a complement to th…
Linköping, SwedenEst. completion Apr 1, 2027
View Trial →
ENDOPLY System in Humans: a Pilot StudyRecruiting
Obesity
Prospective, non-randomized study aimed at defining the initial pattern of gastric plication with the ENDOPLY System, an…
Brno, CzechiaEst. completion Oct 2027
View Trial →
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer PatientsPhase 2Recruiting
Endometrial NeoplasmsAtypical Endometrial HyperplasiaProgesterone ResistanceObesity
To investigate the efficacy of GnRHa plus letrozole in obese progestin-insensitive EEC patients.
Shanghai, ChinaEst. completion Mar 30, 2028
View Trial →
Impact GLP-1 Agonists Following BariatricPhase 4Recruiting
Morbid ObesityMetabolic SyndromeDiabetes MellitusHypertensionObstructive Sleep Apnea of Adult
Glucagon-like peptide 1 (GLP-1) is a hormone that helps regulate blood glucose levels through improved insulin sensitivi…
Columbia, United StatesEst. completion Jul 2028
View Trial →
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusPhase 3Recruiting
Obesity or OverweightWeight-Related ComorbidityWith/Without Diabetes Mellitus, Type 2
The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of A…
Escondido, United StatesEst. completion Aug 9, 2028
View Trial →
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMPhase 3Recruiting
Weight Management
This master study protocol, Study D7260C00015, covers 2 independent, pivotal studies, Study 1 and Study 2. Each study is…
Birmingham, United StatesEst. completion Jul 31, 2028
View Trial →
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body TypesRecruiting
Weight ManagementObesityExerciseWomenGut MicrobiomeMetabolomeHealthGut Microbiota
This study aims to elucidate the differences in the gut microbiome functional activity and metabolome in adult premenopa…
Washington D.C., United StatesEst. completion Jun 1, 2027
View Trial →
A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or ObesityPhase 1Recruiting
HealthyObesity
The main objective of this trial is to establish the bioequivalence of survodutide in a pre-filled syringe (reference pr…
Mannheim, GermanyEst. completion Dec 8, 2026
View Trial →
Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood EnvironmentsRecruiting
Obesity
Background Obesity and physical inactivity contribute substantially to cardiovascular disease risk, diabetes, hypertens…
Bethesda, United StatesEst. completion Aug 4, 2027
View Trial →
A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or ObesityPhase 1Recruiting
ObesityOverweight
The purpose of this clinical study is to find out if NNC0113-5840 is safe for treating people with excess body weight. T…
Glendale, United StatesEst. completion Jan 31, 2027
View Trial →
Cottonseed Oil Versus Matched PUFA EffectsRecruiting
DyslipidemiaOverweight and ObesityNutrition, Healthy
Cardiovascular disease risk factors, including higher BMIs and poor cholesterol profiles, are on the rise and contribute…
Athens, United StatesEst. completion Dec 2026
View Trial →
← PreviousPage 1 of 75Next →
Recruitment Status